AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Z.
Right arrow Articles by Zimmerman, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Z.
Right arrow Articles by Zimmerman, R. A.

American Journal of Neuroradiology, Vol 16, Issue 9 1821-1833, Copyright © 1995 by American Society of Neuroradiology

ARTICLES

Proton MR spectroscopy of pediatric cerebellar tumors

Z Wang, LN Sutton, A Cnaan, JC Haselgrove, LB Rorke, H Zhao, LT Bilaniuk and RA Zimmerman
Department of Radiology, Children's Hospital of Philadelphia, PA 19104- 4345, USA.

PURPOSE: To investigate the role of proton MR spectroscopy in pediatric cerebellar tumor diagnosis. METHODS: Single voxel pulse sequences with long echo time (135 or 270 milliseconds, voxel size 8 to 19 cm3), were used to obtain proton spectra of primary pediatric cerebellar tumors. Eleven primitive neuroectodermal tumors (patient age, 2 to 12 years; mean, 7 years), 11 low-grade astrocytomas (age, 2 to 16 years; mean, 9 years), 4 ependymomas (age, 1 to 6 years; mean, 4 years), 1 mixed glioma ependymo-astrocytoma (age, 11 years), 1 anaplastic ependymoma (age, 7 years), 1 ganglioglioma (age, 14 years), and 1 malignant teratoma (age, 6 days) were studied. Control cerebellum spectra were acquired from five patients without abnormality in cerebellum (age, 2 to 15 years; mean, 8 years). The signal intensities from choline- containing compounds (Cho), creatine/phosphocreatine (Cr), N-acetyl- aspartate (NAA), and lactate (Lac) were quantified. The mean and standard deviation of metabolite ratios were calculated. RESULTS: The control spectra ratios (NAA:Cho = 1.49 +/- 0.36, Cr:Cho = 1.13 +/- 0.23) were distinct from the tumor spectra (NAA:Cho = 0.41 +/- 0.27 and Cr:Cho = 0.37 +/- 0.23). Most of primitive neuroectodermal tumors had low NAA:Cho (0.17 +/- 0.09) and Cr:Cho (0.32 +/- 0.19). Compared with primitive neuroectodermal tumors, low-grade astrocytomas and ependymomas had higher NAA:Cho ratio (0.63 +/- 0.19 and 0.39 +/- 0.12). The Cr:Cho ratio was higher for ependymomas (0.60 +/- 0.20) than for astrocytomas (0.27 +/- 0.12) and primitive neuroectodermal tumors. No NAA was found in the malignant teratoma. Lac:Cho ratio was 0.66 +/- 0.40, 0.58 +/- 0.30, and 0.08 +/- 0.12 for astrocytoma, ependymoma, and primitive neuroectodermal tumor, respectively. Lactate was elevated in the mixed glioma ependymo-astrocytoma, ganglioglioma, and teratoma. The NAA and lactate signals were sometimes obscured by lipids in the spectra. Discriminant analysis was carried out using NAA:Cho and Cr:Cho ratios to differentiate the three major tumor types. The sensitivity/specificity values for diagnosing astrocytoma, ependymoma, and primitive neuroectodermal tumor were found to be 0.91/0.84, 0.75/0.92, and 0.82/0.89, respectively, based on this study. CONCLUSION: In many cases, proton MR spectroscopy can be used to help differentiate cerebellar primitive neuroectodermal tumor, low-grade astrocytoma, and ependymoma.


This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
A. C Peet, T. N Arvanitis, D. P Auer, N. P Davies, D. Hargrave, F. A Howe, T. Jaspan, M. O Leach, D. Macarthur, L. MacPherson, et al.
The value of magnetic resonance spectroscopy in tumour imaging
Arch. Dis. Child., September 1, 2008; 93(9): 725 - 727.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
A. Panigrahy, M.D. Krieger, I. Gonzalez-Gomez, X. Liu, J.G. McComb, J.L. Finlay, M.D. Nelson Jr., F.H. Gilles, and S. Bluml
Quantitative Short Echo Time 1H-MR Spectroscopy of Untreated Pediatric Brain Tumors: Preoperative Diagnosis and Characterization
AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 560 - 572.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Kovanlikaya, A. Panigrahy, M. D. Krieger, I. Gonzalez-Gomez, N. Ghugre, J. G. McComb, F. H. Gilles, M. D. Nelson, and S. Bluml
Untreated Pediatric Primitive Neuroectodermal Tumor in Vivo: Quantitation of Taurine with MR Spectroscopy
Radiology, September 1, 2005; 236(3): 1020 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C. Majos, J. Alonso, C. Aguilera, M. Serrallonga, J. J. Acebes, C. Arus, and J. Gili
Adult Primitive Neuroectodermal Tumor: Proton MR Spectroscopic Findings with Possible Application for Differential Diagnosis
Radiology, November 1, 2002; 225(2): 556 - 566.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
C. Dowling, A. W. Bollen, S. M. Noworolski, M. W. McDermott, N. M. Barbaro, M. R. Day, R. G. Henry, S. M. Chang, W. P. Dillon, S. J. Nelson, et al.
Preoperative Proton MR Spectroscopic Imaging of Brain Tumors: Correlation with Histopathologic Analysis of Resection Specimens
AJNR Am. J. Neuroradiol., April 1, 2001; 22(4): 604 - 612.
[Abstract] [Full Text]

Home page
 Neuro OncolHome page
L. L. Cheng, D. C. Anthony, A. R. Comite, P. M. Black, A. A. Tzika, and R. G. Gonzalez
Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy
Neuro-oncol, April 1, 2000; 2(2): 87 - 95.
[Abstract] [PDF]


Copyright © 2008 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X